Retevmo (selpercatinib) NDC 0002-5562

NDC codes

FDA NDC Directory

Product NDC (as listed)0002-5562Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00002-5562Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0002-5562-60	00002556260	60 TABLET, COATED in 1 BOTTLE (0002-5562-60)Marketed from Apr 10, 2024

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Retevmo
Generic name (nonproprietary): selpercatinib
Active ingredients: Selpercatinib — 160 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Eli Lilly and Company
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 218160
Marketing start: Apr 10, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Breast Cancer Resistance Protein Inhibitors (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Multidrug and Toxin Extrusion Transporter 1 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)Rearranged during Transfection (RET) Inhibitors (Mechanism)
Identifiers: Product ID 0002-5562_7481a510-805c-4f99-b6ae-7b44e70f5f55SPL ID 7481a510-805c-4f99-b6ae-7b44e70f5f55
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400002556260 followed by a unit qualifier and the quantity

Package 00002-5562-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under NDA 218160

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 218160
Product	Strength	Form · route	Labeler	Product NDC
Retevmoselpercatinib	Selpercatinib 120 mg/1	Tablet, CoatedOral	Eli Lilly and Company	0002-6120
Retevmoselpercatinib	Selpercatinib 40 mg/1	Tablet, CoatedOral	Eli Lilly and Company	0002-5340
Retevmoselpercatinib	Selpercatinib 80 mg/1	Tablet, CoatedOral	Eli Lilly and Company	0002-6082